Two Sigma Investments, LP Black Diamond Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 84,200 shares of BDTX stock, worth $183,556. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84,200
Previous 183,227 54.05%
Holding current value
$183,556
Previous $853,000 57.09%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$4.2 - $6.58 $415,913 - $651,597
-99,027 Reduced 54.05%
84,200 $366,000
Q2 2024

Aug 14, 2024
SELL
$4.65 - $7.39 $812,992 - $1.29 Million
-174,837 Reduced 48.83%
183,227 $853,000
Q1 2024

May 15, 2024
SELL
$2.67 - $5.74 $24,641 - $52,974
-9,229 Reduced 2.51%
358,064 $1.82 Million
Q4 2023

Feb 14, 2024
BUY
$1.77 - $3.03 $508,289 - $870,122
287,169 Added 358.41%
367,293 $1.03 Million
Q3 2023

Nov 14, 2023
BUY
$2.87 - $4.99 $229,955 - $399,818
80,124 New
80,124 $229,000
Q1 2023

May 15, 2023
SELL
$1.35 - $3.14 $48,478 - $112,757
-35,910 Reduced 25.0%
107,754 $203,000
Q4 2022

Feb 14, 2023
SELL
$1.27 - $2.51 $81,570 - $161,214
-64,229 Reduced 30.9%
143,664 $258,000
Q3 2022

Nov 14, 2022
SELL
$1.68 - $4.01 $88,352 - $210,889
-52,591 Reduced 20.19%
207,893 $351,000
Q2 2022

Aug 15, 2022
SELL
$1.5 - $3.63 $220,408 - $533,388
-146,939 Reduced 36.07%
260,484 $641,000
Q1 2022

May 16, 2022
BUY
$2.66 - $5.61 $283,079 - $597,021
106,421 Added 35.36%
407,423 $1.13 Million
Q4 2021

Feb 14, 2022
BUY
$5.18 - $8.48 $21,735 - $35,582
4,196 Added 1.41%
301,002 $1.6 Million
Q3 2021

Nov 15, 2021
SELL
$8.46 - $12.42 $993,043 - $1.46 Million
-117,381 Reduced 28.34%
296,806 $2.51 Million
Q2 2021

Aug 16, 2021
BUY
$12.19 - $28.17 $3.55 Million - $8.21 Million
291,421 Added 237.38%
414,187 $5.05 Million
Q1 2021

May 17, 2021
SELL
$22.23 - $34.75 $75,004 - $117,246
-3,374 Reduced 2.67%
122,766 $2.98 Million
Q4 2020

Feb 16, 2021
BUY
$29.47 - $35.0 $3.72 Million - $4.41 Million
126,140 New
126,140 $4.04 Million

Others Institutions Holding BDTX

# of Institutions
117
Shares Held
48.8M
Call Options Held
1.84M
Put Options Held
1.93M
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $79.2M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email